Cost-effectiveness of antivirals in HBeAg-positive chronic hepatitis B: Impact of seroconversion and viral suppression

被引：0
|
作者：
Veenstra, David L.
Iloeje, Uche H.
Tafesse, Eskinder
Sullivan, Sean D.
Cross, Anne
Di Bisceglie, Adrian M.
Gish, Robert G.
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A847 / A847
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and-Negative Chronic Hepatitis B
    Oyaguez, Itziar
    Buti, Maria
    Brosa, Max
    Rueda, Magdalena
    Casado, Miguel A.
    [J]. ANNALS OF HEPATOLOGY, 2017, 16 (03) : 358 - 365
  • [2] A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
    D. Eldon Spackman
    David L. Veenstra
    [J]. PharmacoEconomics, 2008, 26 : 937 - 949
  • [3] Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada
    He, Jing
    Bowen, James M.
    Xie, Feng
    Goeree, Ron
    [J]. VALUE IN HEALTH, 2012, 15 (06) : 894 - 906
  • [4] A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B
    Spackman, D. Eldon
    Veenstra, David L.
    [J]. PHARMACOECONOMICS, 2008, 26 (11) : 937 - 949
  • [5] The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore
    Lacey, L. F.
    Gane, E.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2007, 14 (11) : 751 - 766
  • [6] Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom
    Bermingham, Sarah L.
    Hughes, Ralph
    Fenu, Elisabetta
    Sawyer, Laura M.
    Boxall, Elizabeth
    Kennedy, Patrick T.
    Dusheiko, Geoff
    Hill-Cawthorne, Grant
    Thomas, Howard
    [J]. VALUE IN HEALTH, 2015, 18 (06) : 800 - 809
  • [7] Predictive Factors for Early HBeAg Seroconversion in Acute Exacerbation of Patients With HBeAg-Positive Chronic Hepatitis B
    Kim, Hyoung Su
    Kim, Ha Jung
    Shin, Woon Geon
    Kim, Kyung Ho
    Lee, Jin Heon
    Kim, Hak Yang
    Jang, Myoung Kuk
    [J]. GASTROENTEROLOGY, 2009, 136 (02) : 505 - 512
  • [8] HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
    Guangjun Song
    Ruifeng Yang
    Qian Jin
    Juan Liu
    Huiying Rao
    Bo Feng
    Yandi Xie
    [J]. BMC Gastroenterology, 23
  • [9] HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
    Song, Guangjun
    Yang, Ruifeng
    Jin, Qian
    Liu, Juan
    Rao, Huiying
    Feng, Bo
    Xie, Yandi
    [J]. BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [10] COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
    Sheng, F.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A428 - A429
12345